Merck & Co., Inc. (MRK) Stock Price Today
Aura AI Summary
Key Stats
- $358.50BMarket Cap
- 10,180,803Volume
- HealthSector
- $156.4352W High
- $82.4952W Low
- 98 DaysTypical Hold Time
- $405.27BEnterprise Value
- 2.34%Div Yield
- 12% Sell | 88% BuyTrading Activity
Track Merck & Co., Inc. (MRK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Merck & Co., Inc. has traded between a low of $82.49 and a high of $156.43, highlighting its annual price range. Buy and sell Merck & Co., Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Most Recent News
Neostellar Capital trades at 41% discount amid AI sector doubts and IPO uncertainties
Neostellar Capital's shares are trading at a 41% discount to its net asset value due to negative sentiment around its AI-focused portfolio and recent externalization to Magnetar. The company's largest holding, WHOOP, is preparing for a potential IPO,...

Ballard launches Fleet360, a fuel cell lifecycle program with performance guarantees for transit operators.
Ballard Power Systems introduced Fleet360, a comprehensive fuel cell lifecycle program offering performance guarantees up to 250,000 miles for its FCmove-HD+ modules. The program integrates fuel cell data monitoring, technical support, parts assuranc...

Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.